Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
Chikungunya virus (CHIKV), an alphavirus, has recently caused epidemic outbreaks and is therefore considered a re-emerging pathogen for which no effective treatment is available. In this study, a CHIKV replicon containing the virus replicase proteins together with puromycin acetyltransferase, EGFP a...
Guardado en:
Autores principales: | Leena Pohjala, Age Utt, Margus Varjak, Aleksei Lulla, Andres Merits, Tero Ahola, Päivi Tammela |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/24a78474c21d42d3bade824f3d0b1d7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SNAP-tagged Chikungunya Virus Replicons Improve Visualisation of Non-Structural Protein 3 by Fluorescence Microscopy
por: Roland Remenyi, et al.
Publicado: (2017) -
Facile method for delivering chikungunya viral replicons into mosquitoes and mammalian cells
por: Hui-Chung Lin, et al.
Publicado: (2021) -
Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry
por: Hamid Salimi, et al.
Publicado: (2020) -
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
por: Alexander Karlas, et al.
Publicado: (2016) -
Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus
por: Igor Andrade Santos, et al.
Publicado: (2021)